UA7206A1 - Спосіб одержання гідрохлориду n,n-діметіл-1-[1-(4-хлорфеніл)-циклобутіл]-3-метілбутіламіна у вигляді моногідрату - Google Patents

Спосіб одержання гідрохлориду n,n-діметіл-1-[1-(4-хлорфеніл)-циклобутіл]-3-метілбутіламіна у вигляді моногідрату

Info

Publication number
UA7206A1
UA7206A1 UA4028642A UA4028642A UA7206A1 UA 7206 A1 UA7206 A1 UA 7206A1 UA 4028642 A UA4028642 A UA 4028642A UA 4028642 A UA4028642 A UA 4028642A UA 7206 A1 UA7206 A1 UA 7206A1
Authority
UA
Ukraine
Prior art keywords
cyclobutyl
chlorophenyl
dimethyl
producing
hydrochloride monohydrate
Prior art date
Application number
UA4028642A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Едвард Джеффері Джеймс
Вайбрау Дерек
Original Assignee
Дзе Бутс Компані Плс
Дзе Бутс Компани ПЛС
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10589895&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA7206(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Дзе Бутс Компані Плс, Дзе Бутс Компани ПЛС filed Critical Дзе Бутс Компані Плс
Publication of UA7206A1 publication Critical patent/UA7206A1/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/29—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
UA4028642A 1985-12-17 1986-12-15 Спосіб одержання гідрохлориду n,n-діметіл-1-[1-(4-хлорфеніл)-циклобутіл]-3-метілбутіламіна у вигляді моногідрату UA7206A1 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858531071A GB8531071D0 (en) 1985-12-17 1985-12-17 Therapeutic compound

Publications (1)

Publication Number Publication Date
UA7206A1 true UA7206A1 (uk) 1995-06-30

Family

ID=10589895

Family Applications (1)

Application Number Title Priority Date Filing Date
UA4028642A UA7206A1 (uk) 1985-12-17 1986-12-15 Спосіб одержання гідрохлориду n,n-діметіл-1-[1-(4-хлорфеніл)-циклобутіл]-3-метілбутіламіна у вигляді моногідрату

Country Status (34)

Country Link
US (2) US4929629A (cs)
EP (1) EP0230742B1 (cs)
JP (1) JPS62155240A (cs)
KR (1) KR940008913B1 (cs)
CN (1) CN1016245B (cs)
AT (1) ATE56942T1 (cs)
AU (1) AU601167B2 (cs)
CA (1) CA1266278A (cs)
CS (1) CS259545B2 (cs)
DD (1) DD263050A5 (cs)
DE (1) DE3674570D1 (cs)
DK (1) DK170770B1 (cs)
EG (1) EG17770A (cs)
ES (1) ES2018163T4 (cs)
FI (1) FI90413C (cs)
GB (1) GB8531071D0 (cs)
GE (1) GEP19970812B (cs)
GR (1) GR3001069T3 (cs)
HU (1) HU201901B (cs)
IE (1) IE59429B1 (cs)
IL (1) IL80934A (cs)
IN (1) IN163129B (cs)
LU (1) LU90865I2 (cs)
MX (1) MX4684A (cs)
NL (1) NL300065I1 (cs)
NO (2) NO165540C (cs)
NZ (1) NZ218578A (cs)
PH (1) PH22481A (cs)
PL (1) PL149519B1 (cs)
PT (1) PT83958B (cs)
SU (1) SU1443796A3 (cs)
UA (1) UA7206A1 (cs)
YU (1) YU46033B (cs)
ZA (1) ZA869078B (cs)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8704777D0 (en) * 1987-02-28 1987-04-01 Boots Co Plc Medical treatment
CA2138998A1 (en) * 1992-06-23 1994-01-06 James W. Young Methods and compositions for treating depression and other disorders using optically pure(-) sibutramine
CA2139000A1 (en) * 1992-06-23 1994-01-06 James W. Young Methods and compositions for treating depression and other disorders using optically pure(+) sibutramine
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment
DE4443891A1 (de) * 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
GB9619757D0 (en) 1996-09-21 1996-11-06 Knoll Ag Chemical process
GB9619961D0 (en) * 1996-09-25 1996-11-13 Knoll Ag Medical treatment
GB9619962D0 (en) * 1996-09-25 1996-11-13 Knoll Ag Medical treatment
GB9727131D0 (en) 1997-12-24 1998-02-25 Knoll Ag Therapeutic agents
US6476078B2 (en) * 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6331571B1 (en) 1998-08-24 2001-12-18 Sepracor, Inc. Methods of treating and preventing attention deficit disorders
US6974838B2 (en) * 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
US6339106B1 (en) 1999-08-11 2002-01-15 Sepracor, Inc. Methods and compositions for the treatment and prevention of sexual dysfunction
US6696495B2 (en) * 1998-12-02 2004-02-24 Snowden Pharmaceuticals, Llc Treatment of disorders secondary to organic impairments
US6323242B1 (en) 1998-12-02 2001-11-27 Peter Sterling Mueller Treatment of disorders secondary to organic impairments
ID30432A (id) * 1999-01-20 2001-12-06 Knoll Pharmaceutical Co Metode untuk membantu menghentikan merokok
BG65170B1 (bg) * 1999-03-17 2007-05-31 Knoll Gmbh Използване на n-заместени производни на 1-[1-(4-хлорофенил)циклобутил]-3-метилбутиламин за производство на лекарство за лечение на разстройства при храненето
WO2000056306A1 (en) * 1999-03-19 2000-09-28 Knoll Gmbh Treatment of osteoarthritis
US6376554B1 (en) 1999-03-19 2002-04-23 Knoll Pharmaceutical Company Method of treating sexual dysfunction
AU3895300A (en) 1999-03-19 2000-10-09 Knoll Pharmaceutical Company Treatment of chronic fatigue syndrome
US6803387B1 (en) 1999-03-19 2004-10-12 Abbott Gmbh & Co. Kg Treatment of neuropathic pain or fibromyalgia
US6552087B1 (en) 1999-03-19 2003-04-22 Abbott Gmbh & Co. Kg Therapeutic agent comprising (+)-sibutramine
HK1044462B (en) * 1999-03-19 2006-03-03 Abbott Gmbh & Co. Kg Use of sibutramine or its derivative for the treatment of sleep disorders
AU3760600A (en) 1999-03-19 2000-10-09 Knoll Pharmaceutical Company Treatment of orthostatic hypotension
US6433020B1 (en) 1999-03-19 2002-08-13 Knoll Pharmaceutical Company Treatment of cardiovascular disease
US6441046B1 (en) 1999-03-19 2002-08-27 Abbott Gmbh & Co. Kg Control of metabolism
EP1171106A1 (en) * 1999-03-19 2002-01-16 Knoll GmbH Treatment of certain cancers associated with weight gain
WO2000056321A1 (en) 1999-03-19 2000-09-28 Knoll Pharmaceutical Company Treatment of hyperactivity disorders
AU3896900A (en) 1999-03-19 2000-10-09 Knoll Pharmaceutical Company Treatment of pain
MXPA01009468A (es) 1999-03-19 2004-03-19 Knoll Gmbh Tratamiento de hipertension pulmonar.
US6399826B1 (en) 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
US6380200B1 (en) 1999-12-07 2002-04-30 Pfizer, Inc. Combination of aldose reductase inhibitors and selective serotonin reuptake inhibitors for the treatment of diabetic complications
PE20011061A1 (es) 2000-02-01 2001-11-20 Procter & Gamble Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato
US6562974B2 (en) 2000-02-01 2003-05-13 The Procter & Gamble Company Process for making geminal bisphosphonates
US6232347B1 (en) 2000-03-17 2001-05-15 Knoll Pharmaceutical Company Treatment of osteoarthritis
US6610887B2 (en) 2001-04-13 2003-08-26 Sepracor Inc. Methods of preparing didesmethylsibutramine and other sibutramine derivatives
DE60334787D1 (de) * 2002-03-12 2010-12-16 Merck Sharp & Dohme Substituierte amide
WO2004030663A1 (en) * 2002-10-05 2004-04-15 Hanmi Pharm. Co., Ltd. Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate
KR100536750B1 (ko) * 2002-10-05 2005-12-16 한미약품 주식회사 시부트라민 메탄술폰산염의 결정성 반수화물을 포함하는약학 조성물
US20040122033A1 (en) * 2002-12-10 2004-06-24 Nargund Ravi P. Combination therapy for the treatment of obesity
GB0310361D0 (en) * 2003-05-06 2003-06-11 Cipla Ltd Pharmaceutical compound
US7649002B2 (en) 2004-02-04 2010-01-19 Pfizer Inc (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
WO2006056845A1 (en) * 2004-11-23 2006-06-01 Warner-Lambert Company Llc 7-(2h-pyrazol-3-yl)-3, 5-dihyroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia
EP1846359A4 (en) 2005-01-06 2010-03-31 Cj Cheiljedang Corp INORGANIC ACID SALTS OF SIBUTRAMINE
US8283312B2 (en) * 2005-02-04 2012-10-09 The Research Foundation Of State University Of New York Compositions and methods for modulating body weight and treating obesity-related disorders
KR100781882B1 (ko) * 2005-07-12 2007-12-05 주식회사유한양행 시부트라민을 함유하는 약제학적 조성물
EP1912968A1 (en) * 2005-08-04 2008-04-23 Pfizer Limited Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds
WO2007034910A1 (ja) * 2005-09-22 2007-03-29 Eisai R & D Management Co., Ltd. 過食症及び過食症に伴ううつ病の治療用医薬組成物
US8911751B2 (en) * 2005-10-11 2014-12-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions for nasal delivery
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
RS20080371A (en) * 2006-02-23 2009-07-15 Pfizer Limited, Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
US8604244B2 (en) 2010-07-02 2013-12-10 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
MX2009002781A (es) * 2006-09-15 2009-03-30 Reviva Pharmaceuticals Inc Sintesis, metodos de uso y composiciones de cicloalquilmetilaminas .
AU2007320906A1 (en) 2006-11-13 2008-05-22 Pfizer Products Inc. Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof
AU2007323193A1 (en) * 2006-11-20 2008-05-29 Glenmark Pharmaceuticals S.A. Acetylene derivatives as Stearoyl CoA Desaturase inhibitors
ES2382009T3 (es) 2006-12-01 2012-06-04 Bristol-Myers Squibb Company Derivados de N-((3-bencil)-2,2-(bis-fenil-)-propan-1-amina como inhibidores de CETP para el tratamiento de aterosclerosis y enfermedades cardiovasculares
US20080221057A1 (en) * 2007-02-16 2008-09-11 Wyeth Secreted protein ccdc80 regulates adipocyte differentiation
US20080248115A1 (en) * 2007-04-09 2008-10-09 Palepu Nageswara R Combinations of statins and anti-obesity agent
WO2008124122A1 (en) * 2007-04-09 2008-10-16 Scidose, Llc Combinations of statins and anti-obesity agent and glitazones
WO2009037542A2 (en) 2007-09-20 2009-03-26 Glenmark Pharmaceuticals, S.A. Spirocyclic compounds as stearoyl coa desaturase inhibitors
CN102171206B (zh) * 2008-08-06 2014-06-25 辉瑞股份有限公司 作为mc4激动剂的二氮杂环庚烷和二氮杂环辛烷
TWI478712B (zh) 2008-09-30 2015-04-01 Astellas Pharma Inc 釋控性醫藥組成物
WO2010093243A1 (en) 2009-02-12 2010-08-19 Coöperatieve Mirzorg U.A., Arnhem Use of a combination of diazoxide and metformin for treating obesity or obesity related disorders
DK2496583T3 (en) 2009-11-02 2015-02-02 Pfizer Dioxa-bicyclo [3.2.1] octane-2,3,4-triol DERIVATIVES
TR201802207T4 (tr) 2010-03-29 2018-03-21 Astellas Pharma Inc Kontrollü Salımlı Farmasötik Bileşim.
SG186275A1 (en) 2010-07-06 2013-01-30 Astrazeneca Ab Therapeutic agents 976
AU2011326871B2 (en) 2010-11-04 2015-02-12 Albireo Ab IBAT inhibitors for the treatment of liver diseases
DK2637646T3 (en) 2010-11-08 2016-08-29 Albireo Ab PHARMACEUTICAL COMBINATION CONTAINING AN IBAT inhibitor and a bile acid binder
UY34194A (es) 2011-07-15 2013-02-28 Astrazeneca Ab ?(3-(4-(espiroheterocíclico)metil)fenoxi)azetidin-1-il)(5-(fenil)-1,3,4-oxadiazol-2-il)metanona en el tratamiento de la obesidad?
EP2890370B1 (en) 2012-08-31 2019-10-09 The Regents of the University of California Agents useful for treating obesity, diabetes and related disorders
CN110372522B (zh) * 2019-07-30 2020-10-02 南京工业大学 一种从含有戊二胺的固相中汽提回收戊二胺的方法
US12097189B1 (en) 2024-02-09 2024-09-24 Astellas Pharma Inc. Pharmaceutical composition for modified release

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1124485B (de) * 1960-02-12 1962-03-01 Hoechst Ag Verfahren zur Herstellung von analeptisch wirksamen Phenylcycloalkylmethylaminen
SE7600674L (sv) * 1975-02-05 1976-08-06 Rohm & Haas Fungicider
IE52768B1 (en) * 1981-04-06 1988-02-17 Boots Co Ltd 1-arylcyclobutylalkylamine compounds useful as therapeutic agents
US4443449A (en) * 1981-04-06 1984-04-17 The Boots Company Limited Arylcyclobutylalkylamines and anti-depression composition and methods using same
ZA821577B (en) * 1981-04-06 1983-03-30 Boots Co Plc Therapeutic agents
GB2115409B (en) * 1982-02-24 1985-08-07 Zyma Sa Novel crystal modifications of (+)-catechin
DK101683A (da) * 1982-03-12 1983-09-13 Duphar Int Res Phenylpiperazinderivater og fremgangsmaade til fremstilling heraf
IE56001B1 (en) * 1982-09-30 1991-03-13 Boots Co Plc 1-arylcyclobutylmethylamine compounds
IE56000B1 (en) * 1982-09-30 1991-03-13 Boots Co Plc 1-arylcyclobutylalkylamine compounds
ZA836848B (en) * 1982-09-30 1984-05-30 Boots Co Plc Therapeutic agents
GB8501192D0 (en) * 1985-01-17 1985-02-20 Boots Co Plc Therapeutic agents
GB8704777D0 (en) * 1987-02-28 1987-04-01 Boots Co Plc Medical treatment
JP2675573B2 (ja) * 1988-03-31 1997-11-12 科研製薬株式会社 脳機能改善剤
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity

Also Published As

Publication number Publication date
DE3674570D1 (de) 1990-10-31
IL80934A (en) 1990-07-26
NO865093D0 (no) 1986-12-16
KR940008913B1 (ko) 1994-09-28
IN163129B (cs) 1988-08-13
CS930586A2 (en) 1988-02-15
SU1443796A3 (ru) 1988-12-07
CS259545B2 (en) 1988-10-14
HUT45964A (en) 1988-09-28
EP0230742A1 (en) 1987-08-05
FI865030A0 (fi) 1986-12-10
EG17770A (en) 1991-03-30
ZA869078B (en) 1987-07-29
NZ218578A (en) 1989-04-26
LU90865I2 (fr) 2002-02-18
DK585786A (da) 1987-06-18
ES2018163B3 (es) 1991-04-01
FI865030L (fi) 1987-06-18
AU6644286A (en) 1987-06-18
NO165540C (no) 1991-02-27
NL300065I1 (nl) 2001-12-01
DD263050A5 (de) 1988-12-21
US5068440A (en) 1991-11-26
IE863102L (en) 1987-06-17
YU205086A (en) 1987-12-31
NO2005022I1 (no) 2005-10-03
EP0230742B1 (en) 1990-09-26
GR3001069T3 (en) 1992-03-20
FI90413B (fi) 1993-10-29
YU46033B (sh) 1992-12-21
ES2018163T4 (es) 2012-06-14
JPH0144176B2 (cs) 1989-09-26
JPS62155240A (ja) 1987-07-10
CA1266278A (en) 1990-02-27
DK170770B1 (da) 1996-01-15
PT83958A (en) 1987-01-01
ATE56942T1 (de) 1990-10-15
NO165540B (no) 1990-11-19
PH22481A (en) 1988-09-12
KR870005961A (ko) 1987-07-08
PL149519B1 (en) 1990-02-28
CN86108547A (zh) 1987-08-19
PT83958B (pt) 1989-05-12
PL263020A1 (en) 1988-05-12
MX4684A (es) 1993-12-01
HU201901B (en) 1991-01-28
GB8531071D0 (en) 1986-01-29
US4929629A (en) 1990-05-29
IE59429B1 (en) 1994-02-23
DK585786D0 (da) 1986-12-05
AU601167B2 (en) 1990-09-06
NO865093L (no) 1987-06-18
CN1016245B (zh) 1992-04-15
FI90413C (fi) 1994-02-10
GEP19970812B (en) 1997-02-10

Similar Documents

Publication Publication Date Title
UA7206A1 (uk) Спосіб одержання гідрохлориду n,n-діметіл-1-[1-(4-хлорфеніл)-циклобутіл]-3-метілбутіламіна у вигляді моногідрату
NO863527D0 (no) Fremgangsmaate for fremstilling av en emulsjon av olje i vann.
DE3668268D1 (de) Verwendung von cis-n-(2-aminocycloaliphatische) benzen acetamid und benzamid zur herstellung von antikrampfmittel.
NO864554L (no) Flytende oppvaskmiddelblanding for haandvask i kaldt vann.
IT8248666A0 (it) Procedimento per produrre i glicosa minoglicani dermatansolfato ed eparan-solfato sostanzialmente puri eloro impiego farmaceutico
NO872952D0 (no) Katode for bruk i hydrogenutviklende elektrokjemiske prosesser, samt fremgangsmaate til fremstilling av katoden.
DE3781489D1 (de) Befestigungselement zur befestigung von einsaetzen an seitenwaenden einer moebelstruktur.
KR970064396A (ko) 스트레스 완화용 사료
IT8225022A0 (it) Struttura multistratificata per complesso di elettrodo e membrana e procedimento di elettrolisi usante il medesimo.
NO863619L (no) Epoksy-novolak-harpikser, samt fremgangsmaate for fremstilling av slike.
NO862506L (no) Steroido(3,2-c)pyrazoler med antiandrogen virkning og fremgangsmaate for deres fremstilling.
Wheeler Stratigraphy and sedimentology of the Tensleep sandstone, southeast Bighorn Basin, Wyoming
IT8025482A0 (it) Membrana modificata morfologicamente ed uso della stessa in procedimenti di elettrolisi.
IT1136191B (it) Procedimento per la preparazione di lievito naturale allo stato granulato fine trasportabile e conservabile nel tempo
IT8468046A0 (it) Procedimento per la preparazione di monocarburo di tungsteno mediante diffusione di gas contenenti idrocarburi
IT8722055A0 (it) Procedimento per la preparazione di idantoine 5-ariliden e alchilidensostituite.
ES489117A1 (es) Metodo para la preparacion de benzaldehido puro en presenciade agua
IT1223624B (it) Procedimento per l'idrogenazione selettiva di acetileni
IT8219207A0 (it) Membrana modificata morfologicamente ed uso della stessa in procedimenti di elettrolisi.
IT1201252B (it) Procedimento per la decurazione di pelli con vello di pelo ed altro,con coloranti trasferiti da supporto
IT8467251A1 (it) Procedimento catalitico per la decarbossilazione accelerata di carbonato di calcio e miscela utilizzata nel procedimento.
DE58904702D1 (de) Beta-phenoxyethylamine und deren verwendung zur herstellung von farbstoffen.
Chappell The azimuth of language: explorations into the limits of expression
IT1194342B (it) Processo per la preparazione di '-(1-metil-4-piperidilidene)-4,9-diidrotieno(2,3-c)-2-benzotiepina e relativo idrogeno(+)tartrato
Hinohara Tracheostomy: Indications and Post-operative Care